866-997-4948(US-Canada Toll Free)

Global Alpha 1 Antitrypsin Deficiency Treatment Market Research Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 101 Pages

This report studies the global Alpha 1 Antitrypsin Deficiency Treatment market status and forecast, categorizes the global Alpha 1 Antitrypsin Deficiency Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma.
The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.
Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).
The global Alpha 1 Antitrypsin Deficiency Treatment market is valued at 1190 million US$ in 2017 and will reach 2560 million US$ by the end of 2025, growing at a CAGR of 10.1% during 2018-2025.

The major manufacturers covered in this report
Pfizer
Baxter
AstraZeneca
Grifols
Teva Pharmaceutical Industries
Boehringer Ingelheim
Kamada Ltd
GlaxoSmithKline
CSL Behring
Shire
LFB Biomedicaments
Abeona Therapeutics
Biogen
Applied Genetic Technologies
Baxalta
Arrowhead Research Corporation
ProBioGen
Chiesi Pharmaceuticals
Curaxys
ProMetic Life Sciences

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Augmentation Therapy
Bronchodilators
Corticosteroids
Oxygen Therapy
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Specialty Clinics
Pharmacies

The study objectives of this report are:
To analyze and study the global Alpha 1 Antitrypsin Deficiency Treatment sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Alpha 1 Antitrypsin Deficiency Treatment manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Alpha 1 Antitrypsin Deficiency Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Alpha 1 Antitrypsin Deficiency Treatment Manufacturers
Alpha 1 Antitrypsin Deficiency Treatment Distributors/Traders/Wholesalers
Alpha 1 Antitrypsin Deficiency Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Alpha 1 Antitrypsin Deficiency Treatment market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Alpha 1 Antitrypsin Deficiency Treatment Market Research Report 2018
1 Alpha 1 Antitrypsin Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Alpha 1 Antitrypsin Deficiency Treatment
1.2 Alpha 1 Antitrypsin Deficiency Treatment Segment by Type (Product Category)
1.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Type (Product Category) in 2017
1.2.3 Augmentation Therapy
1.2.4 Bronchodilators
1.2.5 Corticosteroids
1.2.6 Oxygen Therapy
1.3 Global Alpha 1 Antitrypsin Deficiency Treatment Segment by Application
1.3.1 Alpha 1 Antitrypsin Deficiency Treatment Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Pharmacies
1.4 Global Alpha 1 Antitrypsin Deficiency Treatment Market by Region (2013-2025)
1.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Alpha 1 Antitrypsin Deficiency Treatment (2013-2025)
1.5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Status and Outlook (2013-2025)
1.5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production Status and Outlook (2013-2025)

2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Competition by Manufacturers
2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production and Share by Manufacturers (2013-2018)
2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Share by Manufacturers (2013-2018)
2.3 Global Alpha 1 Antitrypsin Deficiency Treatment Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Alpha 1 Antitrypsin Deficiency Treatment Market Competitive Situation and Trends
2.5.1 Alpha 1 Antitrypsin Deficiency Treatment Market Concentration Rate
2.5.2 Alpha 1 Antitrypsin Deficiency Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity and Market Share by Region (2013-2018)
3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production and Market Share by Region (2013-2018)
3.3 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Alpha 1 Antitrypsin Deficiency Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption by Region (2013-2018)
4.2 North America Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.4 China Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.5 Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)
4.7 India Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export, Import (2013-2018)

5 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production and Market Share by Type (2013-2018)
5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
5.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price by Type (2013-2018)
5.4 Global Alpha 1 Antitrypsin Deficiency Treatment Production Growth by Type (2013-2018)

6 Global Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Application
6.1 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption and Market Share by Application (2013-2018)
6.2 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Alpha 1 Antitrypsin Deficiency Treatment Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Baxter
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 AstraZeneca
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Grifols
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Teva Pharmaceutical Industries
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Kamada Ltd
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 GlaxoSmithKline
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 CSL Behring
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Shire
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Alpha 1 Antitrypsin Deficiency Treatment Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Shire Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 LFB Biomedicaments
7.12 Abeona Therapeutics
7.13 Biogen
7.14 Applied Genetic Technologies
7.15 Baxalta
7.16 Arrowhead Research Corporation
7.17 ProBioGen
7.18 Chiesi Pharmaceuticals
7.19 Curaxys
7.20 ProMetic Life Sciences

8 Alpha 1 Antitrypsin Deficiency Treatment Manufacturing Cost Analysis
8.1 Alpha 1 Antitrypsin Deficiency Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Alpha 1 Antitrypsin Deficiency Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Alpha 1 Antitrypsin Deficiency Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Alpha 1 Antitrypsin Deficiency Treatment Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Alpha 1 Antitrypsin Deficiency Treatment Market Forecast (2018-2025)
12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Alpha 1 Antitrypsin Deficiency Treatment Price and Trend Forecast (2018-2025)
12.2 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Alpha 1 Antitrypsin Deficiency Treatment
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Augmentation Therapy
Table Major Manufacturers of Augmentation Therapy
Figure Product Picture of Bronchodilators
Table Major Manufacturers of Bronchodilators
Figure Product Picture of Corticosteroids
Table Major Manufacturers of Corticosteroids
Figure Product Picture of Oxygen Therapy
Table Major Manufacturers of Oxygen Therapy
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) by Applications (2013-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Applications in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Specialty Clinics Examples
Table Key Downstream Customer in Specialty Clinics
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Major Players Product Capacity (K Units) (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity (K Units) of Key Manufacturers in 2017
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity (K Units) of Key Manufacturers in 2018
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Major Players Product Production (K Units) (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) of Key Manufacturers (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Manufacturers (2013-2018)
Figure 2017 Alpha 1 Antitrypsin Deficiency Treatment Production Share by Manufacturers
Figure 2017 Alpha 1 Antitrypsin Deficiency Treatment Production Share by Manufacturers
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Major Players Product Revenue (Million USD) (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers
Table 2018 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers
Table Global Market Alpha 1 Antitrypsin Deficiency Treatment Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Alpha 1 Antitrypsin Deficiency Treatment Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Product Category
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Share of Top 3 Manufacturers
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Share of Top 5 Manufacturers
Table Global Alpha 1 Antitrypsin Deficiency Treatment Capacity (K Units) by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity Market Share by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity Market Share by Region (2013-2018)
Figure 2017 Global Alpha 1 Antitrypsin Deficiency Treatment Capacity Market Share by Region
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Region (2013-2018)
Figure 2017 Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share by Region
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) by Region (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Region (2013-2018)
Table 2017 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Region
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) Market by Region (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Region (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Region (2013-2018)
Figure 2017 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) Market Share by Region
Table North America Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Type (2013-2018)
Figure Production Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure 2017 Production Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Type
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Alpha 1 Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure 2017 Revenue Market Share of Alpha 1 Antitrypsin Deficiency Treatment by Type
Table Global Alpha 1 Antitrypsin Deficiency Treatment Price (USD/Unit) by Type (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Growth by Type (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) by Application (2013-2018)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Application (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Applications (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share by Application in 2017
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Growth Rate by Application (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (Pfizer) and Gross Margin (2013-2018)
Figure Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Pfizer Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Pfizer Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Baxter Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Baxter Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Grifols Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Grifols Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Kamada Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire Alpha 1 Antitrypsin Deficiency Treatment Production Growth Rate (2013-2018)
Figure Shire Alpha 1 Antitrypsin Deficiency Treatment Production Market Share (2013-2018)
Figure Shire Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha 1 Antitrypsin Deficiency Treatment
Figure Manufacturing Process Analysis of Alpha 1 Antitrypsin Deficiency Treatment
Figure Alpha 1 Antitrypsin Deficiency Treatment Industrial Chain Analysis
Table Raw Materials Sources of Alpha 1 Antitrypsin Deficiency Treatment Major Manufacturers in 2017
Table Major Buyers of Alpha 1 Antitrypsin Deficiency Treatment
Table Distributors/Traders List
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Price (Million USD) and Trend Forecast (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) Forecast by Region (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Market Share Forecast by Region (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Share Forecast by Region (2018-2025)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Alpha 1 Antitrypsin Deficiency Treatment Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) Forecast by Type (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production (K Units) Forecast by Type (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Price Forecast by Type (2018-2025)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *